Synthesis of novel isoxazolidine analogues of homonucleosides
摘要:
A general method for the synthesis of nucleobase-derived nitrones 4a-e by treatment of N-(2-oxoethyl)nucleobases with N-methylhydroxylamine is reported. The nitrones 4a-e were applied in the synthesis of isoxazolidine homonucleosides. Moderate diastereoselectivities (de 28-82%) were observed for cycloadditions between nitrones 4a-e and allyl alcohol with cis-isoxazolidines predominating. The stereochemistry of the substituted isoxazolidines was established based on an analysis of 2D NOE experiments for uracil-containing cycloadducts 6a and 7a. Cycloadditions of uracil-based nitrone 4a with vinyl-, allyl-, vinyloxymethyl- and allyloxymethylphosphonates gave the respective phosphonylated cis-isoxazolidines as the major adducts. (C) 2012 Elsevier Ltd. All rights reserved.
Nucleobase-Derived Nitrones: Synthesis and Antioxidant and Neuroprotective Activities in an In Vitro Model of Ischemia–Reperfusion
作者:Beatriz Chamorro、Iwona E. Głowacka、Joanna Gotkowska、Rafał Gulej、Dimitra Hadjipavlou-Litina、Francisco López-Muñoz、José Marco-Contelles、Dorota G. Piotrowska、María Jesús Oset-Gasque
DOI:10.3390/ijms23063411
日期:——
-phenyl-N-tert-butylnitrone (PBN) and are similar to N-acetyl-L-cysteine (NAC), a well-known antioxidant and neuroprotectiveagent. The nitrones with the highest neuroprotective capacity were those containing purine nucleobases (nitrones 9f, g, B = adenine, theophylline), followed by nitrones with pyrimidine nucleobases with H or F substituents at the C5 position (nitrones 9a, c). All of these possess EC50 values
在此,我们报告了一些命名为9a - i的核碱基衍生硝酮的合成、抗氧化和神经保护特性。使用人神经母细胞瘤 SH-SY5Y 细胞针对氧-葡萄糖剥夺体外缺血模型测量硝酮9a -i的神经保护特性。我们的结果表明,硝酮9a -i比 -苯基-N-叔丁基硝酮 ( PBN ) 具有更好的神经保护和抗氧化特性,并且类似于 N-乙酰基-L-半胱氨酸 ( NAC ),一种众所周知的抗氧化剂和神经保护剂代理人。具有最高神经保护能力的硝酮是那些含有嘌呤碱基的硝酮(硝酮9f、g、 B = 腺嘌呤,茶碱),然后是在 C5 位带有 H 或 F 取代基的嘧啶核碱基的硝酮(硝酮9a,c)。所有这些都具有 1-6 M 范围内的 EC 50值和高于 100% 的最大活性。然而,引入甲基取代基(硝酮9b, B = 胸腺嘧啶)或硬卤素取代基如 Br 和 Cl(分别为硝酮9 d,e , B = 5-Br 和 5-Cl 尿嘧啶)会降低神经保护活性以尿嘧啶为核碱基的硝酮
Bi-functional complexes and methods for making and using such complexes
申请人:Gouliaev Alex Haahr
公开号:US11225655B2
公开(公告)日:2022-01-18
The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
Synthesis of CMP-sialic Acid Mimics That Have 5-Fluorouracil for Cytosine and the C-Terminal's Peptide Bond for the Phosphate Group: Targeting Inhibitors of Sialyltransferases
BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
申请人:Nuevolution A/S
公开号:EP2558577A1
公开(公告)日:2013-02-20
BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
申请人:Gouliaev Alex Haahr
公开号:US20130281324A1
公开(公告)日:2013-10-24
The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.